Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Jia · SciRah

Researcher profile · Semantic Scholar

J. Jia

Share profile

J. Jia — researcher profile on SciRah

h-index: 13
Works: 40
Citations: 625

Most-cited papers

Patient-derived micro-organospheres (MOS) enable clinical precision oncology
S. Ding, Carolyn Hsu, Zhaohui Wang, Naveen R. Natesh +33 more
2022Cell Stem Cell204 citations Open access
Semantic Scholar
High expression of macrophage colony-stimulating factor-1 receptor in peritumoral liver tissue is associated with poor outcome in hepatocellular carcinoma after curative resection.
J. Jia, Wen-Quan Wang, Hui-Chuan Sun, Xiao-Dong Zhu +10 more
2010The Oncologist64 citations Open access
Semantic Scholar
Phase I Study of Bevacizumab, Everolimus, and Panobinostat (LBH-589) in Advanced Solid Tumors
J. Strickler, A. Starodub, J. Jia, K. Meadows +8 more
2012Cancer Chemotherapy and Pharmacology41 citations Open access
Semantic Scholar
Germline transcription from T‐cell receptor Vβ gene is uncoupled from allelic exclusion
J. Jia, M. Kondo, Yuan Zhuang
2007EMBO Journal35 citations Open access
Semantic Scholar
Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival
J. Jia, Peng-Yuan Zhuang, Hui-Chuan Sun, Ju-Bo Zhang +5 more
2009Journal of Cancer Research and Clinical Oncology31 citations Open access
Semantic Scholar
A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice
J. Jia, Wen-Quan Wang, Hui-Chuan Sun, Liang Liu +10 more
2011Investigational new drugs28 citations
Semantic Scholar
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
G. Vlahović, K. Meadows, A. Hatch, J. Jia +15 more
2018The Oncologist21 citations Open access
Semantic Scholar
Dual Inhibition of AlphaV Integrins and Src Kinase Activity as A Combination Therapy Strategy for Colorectal Cancer
J. Jia, A. Starodub, I. Cushman, Ying-Miao Liu +3 more
2013Anti-Cancer Drugs20 citations Open access
Semantic Scholar
Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)
A. Hatch, Alexander B. Sibley, Mark D. Starr, J. Brady +10 more
2016Cancer Medicine19 citations Open access
Semantic Scholar
Dasatinib (BMS-35482) potentiates the activity of gemcitabine and docetaxel in uterine leiomyosarcoma cell lines
M. Lopez-Acevedo, Lisa A. Grace, D. Teoh, R. Whitaker +4 more
2014Gynecologic Oncology Research and Practice19 citations Open access
Semantic Scholar
E proteins are required to activate germline transcription of the TCR Vβ8.2 gene
J. Jia, M. Dai, Yuan Zhuang
2008European Journal of Immunology18 citations Open access
Semantic Scholar
Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer.
J. Strickler, Christel N. Rushing, H. Uronis, M. Morse +16 more
2021The Oncologist17 citations Open access
Semantic Scholar
Cell-Free DNA Profiling to Discover Mechanisms of Exceptional Response to Cabozantinib Plus Panitumumab in a Patient With Treatment Refractory Metastatic Colorectal Cancer
J. Jia, M. Morse, R. Nagy, R. Lanman +1 more
2018Frontiers in Oncology17 citations Open access
Semantic Scholar
A phase II single-arm study of the FGFR inhibitor pemigatinib in patients with metastatic colorectal cancer (mCRC) harboring FGF/FGFR alterations.
K. Ciombor, T. Zemla, J. Hubbard, J. Jia +7 more
2023Journal of Clinical Oncology12 citations
Semantic Scholar
Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes.
J. Jia, De-Wu Han, Rui-Ling Xu, Fei Gao +4 more
1998World Journal of Gastroenterology12 citations Open access
Semantic Scholar
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
H. Uronis, J. Jia, J. Bendell, L. Howard +7 more
2015Cancer Chemotherapy and Pharmacology10 citations
Semantic Scholar
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers
J. Jia, L. Howard, Ying-Miao Liu, Mark D. Starr +4 more
2022Cancer Chemotherapy and Pharmacology8 citations
Semantic Scholar
The natural history of fibroblast growth factor receptor (FGFR)-altered cholangiocarcinoma (CCA).
L. Goyal, A. Lamarca, J. Strickler, M. Cecchini +16 more
20208 citations
Semantic Scholar
A Phase I Study of Gemcitabine + Dasatinib (GD) or Gemcitabine + Dasatinib + Cetuximab (GDC) in Refractory Solid Tumors
N. Mettu, D. Niedzwiecki, Christel N. Rushing, A. Nixon +6 more
2019Cancer Chemotherapy and Pharmacology7 citations Open access
Semantic Scholar
Acute Pancreatitis Associated With Ado-Trastuzumab Emtansine.
M. Muzaffar, J. Jia, D. Liles, M. Naveed +1 more
2016American Journal of Therapeutics7 citations
Semantic Scholar
Dasatinib (BMS-35482) interacts synergistically with docetaxel, gemcitabine, topotecan and doxorubicin in ovarian cancer cells with high SRC pathway activation and protein expression
A. Secord, D. Teoh, J. Jia, A. Nixon +3 more
2014International Journal of Gynecologic Cancer7 citations Open access
Semantic Scholar
Direct Evidence of Target Inhibition with anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing
J. Jia, A. Dellinger, Eric S. Weiss, A. Bulusu +7 more
2015Clinical Cancer Research6 citations Open access
Semantic Scholar
A case report of microsatellite instability (MSI)-high, HER2 amplified pancreatic adenocarcinoma with central nervous system metastasis.
N. DeVito, C. Kelleher, K. Strickland, J. Abbruzzese +9 more
2021AME Case Reports4 citations Open access
Semantic Scholar
A phase I/II trial of cabozantinib (C) with or without panitumumab (P) in patients (pts) with RAS wild-type (WT) metastatic colorectal cancer (mCRC): Clinical outcomes in pts with MET amplification (amp) detected in blood.
J. Jia, D. Niedzwiecki, H. Uronis, M. Morse +9 more
20184 citations
Semantic Scholar
A phase II study of savolitinib (volitinib, AZD6094, HMPL-504) in subjects with MET amplified metastatic colorectal cancer (mCRC) detected by cell-free (cf)DNA.
J. Jia, D. Niedzwiecki, C. Arrowood, Nancy Garett-Mead +5 more
20203 citations
Semantic Scholar
Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma
Zhen-Yu Xiao, J. Jia, Lin Chen, W. Zou +1 more
2012Medical Oncology3 citations
Semantic Scholar
Microorganospheres as a novel precision oncology platform in colorectal cancer.
Carolyn Hsu, Zhaohui Wang, Sehwa Oh, G. Rupprecht +6 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
[Effects of pioglitazone on the morphology and the expression of connective tissue growth factor of transforming growth factor beta-induced rat hepatic stellate cells in vitro].
J. Jia, Yan Liu, Wei-Hua Chen, Mei Liu +1 more
2007Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2 citations
Semantic Scholar
Ultra-sensitive, tumor-informed ctDNA profiling in patients with gastroesophageal cancer and treated with pembrolizumab and longitudinal ctDNA kinetics.
A. Nixon, L. McDaniel, J. Jia, Charles Abbott +8 more
2023Journal of Clinical Oncology0 citations
Semantic Scholar
Prediction model for detecting circulating tumor DNA (ctDNA) in metastatic colorectal cancer (mCRC).
A. L. Lima Pereira, A. Parikh, E. V. Van Seventer, J. Jia +11 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Dual inhibition of {alpha}V integrins and Src kinase activity in colon cancer cells
A. Starodub, J. Jia, S. Cushman, D. Marshall +2 more
20160 citations
Semantic Scholar
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance).
A. Hatch, H. Pang, Mark D. Starr, J. Brady +6 more
20140 citations
Semantic Scholar
Direct Evidence of Targeted Inhibition by Anti-angiogenic Agents from a Wound-healing Model in Patients with Advance Solid Tumors
J. Jia, A. Dellinger, Esther M Weiss, A. Bulusu +6 more
20140 citations
Semantic Scholar
Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors
J. Jia, Haiyan Li, A. Dellinger, H. Pang +3 more
20120 citations
Semantic Scholar
Effect of IGF-1 on PI3K/Akt/mTOR pathway in Rh1 sarcoma cells
J. Jia
20110 citations
Semantic Scholar
Abstract 1556: A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma
J. Jia, Wen-Quan Wang, Hui-Chuan Sun, Liang Liu +7 more
20100 citations
Semantic Scholar
Dual inhibition of αV integrins and Src kinase activity in colon cancer cells.
A. Starodub, J. Jia, S. Cushman, D. Marshall +2 more
2009Journal of Clinical Oncology0 citations
Semantic Scholar
Role of monocyte chemoattractant protein-1 in pathogenesis of severe acute pancreatitis
J. Jia
20080 citations
Semantic Scholar
VEGF, VEGFR and their impact on angiogenesis of hepatocellular carcinoma
J. Jia
20080 citations
Semantic Scholar
The Possibility of TAFIa as A Target of Anti-thrombosis
J. Jia
20070 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Nixon×15
Invite
A. Nixon — researcher profile on SciRah
H. Hurwitz×13
Invite
H. Hurwitz — researcher profile on SciRah
J. Strickler×10
Invite
J. Strickler — researcher profile on SciRah
H. Uronis×8
Invite
H. Uronis — researcher profile on SciRah

×8

Invite

D. Niedzwiecki — researcher profile on SciRah

Invite

H. Pang — researcher profile on SciRah

A. Dellinger×5

Invite

A. Dellinger — researcher profile on SciRah

Invite

S. Haley — researcher profile on SciRah

Hui-Chuan Sun×4

Invite

Hui-Chuan Sun — researcher profile on SciRah

Xiao-Dong Zhu×4

Invite

Xiao-Dong Zhu — researcher profile on SciRah

Invite

Wei Zhang — researcher profile on SciRah

Hua-Xiang Xu×4

Invite

Hua-Xiang Xu — researcher profile on SciRah